title: Gynecomastia and potent antiretroviral therapy.
authors.forename: Christoph
authors.initials: C
authors.lastname: Strub
authors.forename: Gilbert R
authors.initials: GR
authors.lastname: Kaufmann
authors.forename: Markus
authors.initials: M
authors.lastname: Flepp
authors.forename: Martin
authors.initials: M
authors.lastname: Egger
authors.forename: Christian
authors.initials: C
authors.lastname: Kahlert
authors.forename: Matthias
authors.initials: M
authors.lastname: Cavassini
authors.forename: Manuel
authors.initials: M
authors.lastname: Battegay
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D016022:Case-Control Studies; D016049:Didanosine / Q000009:adverse effects; D005260:Female; D006177:Gynecomastia / Q000139:chemically induced* / Q000821:virology; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D008297:Male; D018119:Stavudine / Q000009:adverse effects
chemical_list: D019380:Anti-HIV Agents; D018119:Stavudine; D016049:Didanosine